



"Pricing Transparency Is What We Want"
Medtronic, the $29-billion global medical technology major, is a key member of US lobby group Advanced Medical Technology Association (AdvaMed) that wants the US to punish India for capping prices of medical devices and medicines. But AdvaMed's stand does not stand in the way of Medtronic's plans to strengthen its engagement with India. Omar Ishrak,Chairman and CEO, Medtronic, talks with BT's Joe C Mathew about advancements in medical technology, need for fair pricing of medical devices and the promise India's flagship health assurance programme, Ayushman Bharat, holds. Edited excerpts:With increased internet penetration, merchant acceptance network is trying to catch up with newer methods of digital payments.With interoperability paving the path for a level playing field, non-bank digital wallets are set to attract more users, but competition could be fierce.Payments grow at a super fast pace but regulatory challenges remain.Increasing adoption of UPI through bank wallets and third-party players such as Flipkart's Phone Pe, Amazon Pay and Google Tez is changing the payments sector.The changed business environment had hit the once-monolithic BHEL hard. It is trying to move with the times, but pitfalls remain.Fintech For Inclusion: Challenges And Opportunities
Getting access and then converting it to inclusion and adoption through appropriate products is the target.The government plans to bolster non-oil exports. But for that it needs to act on a war footing to arrest the fall in some of India's biggest exporting sectors.Market changes and increased regulatory oversight in the US have hurt Lupin, but India's third-biggest drug maker is making efforts to come back.Keeping with its tradition of creating a branded play out of highly unorganised businesses, Titan has ventured into saris. But can this, and some of its other smaller businesses, help it become a Rs 52,000-crore company by 2023?Numbers clearly indicate that the Indian fintech ecosystem is fast evolving.
Rupee Recovers From Record Low
The depreciation was largely on account of rising crude oil prices that touched $86 barrel a couple of months ago from less than $40 a barrel in 2014 and hardening interest rates in the US.


